Skip navigation

Nicoccino: Innovative tobacco, tar and smoke-free nicotine product

London, UK, 11 January 2016 – With the use of e-cigarettes becoming increasingly restricted and with the Nicotine Replacement Therapy (NRT) market declining, Nicoccino has arrived just in time to provide smokers with a more satisfying pure nicotine experience.

Nicoccino is a leaf thin, dissolvable strip that is folded and placed under the lip and against the gum to dissolve and deliver a powerful, instant hot shot of pure, clean nicotine. Smokers feel a hot sensation as the nicotine absorbs, so they know it is working.

James Higgs, International Marketing Director at Nicoccino, explains the product has been developed to reflect the rapid nicotine uptake of a cigarette, bioequivalent to one of the quickest NRT’s*.

“Nicoccino is not an NRT; it’s an alternative nicotine consumer product.”
says Higgs, adding: “Smokers are actively seeking an effective alternative and Nicoccino provides a tobacco free nicotine delivery.”

Nicoccino is produced to pharmaceutical standards*** and is made from a natural alginate base with a natural lemon mint flavouring and thanks to its high pH level, it gets nicotine quickly into the bloodstream. It packs an instant, powerful punch – literally a hot shot. Every film delivers enough nicotine for smokers to get the satisfaction they are looking for.

Not only is Nicoccino satisfying, fast-acting and long-lasting it can be enjoyed anytime, anywhere; whether at work, socialising or travelling.

This innovative product is liberating smokers around the world. Available now at £4.99 for a pack of 10, the Nicoccino packs come in easy shelf-ready displays, and attractive cherry wood display units.

For more information, visit Nicoccino’s webpage


Nicoccino PK/BE study*
A Pharma Kinetic /BE clinical study on 40 healthy smoker was completed in September 2012. The study design is an open cross over study with Buccal Trans Mucosal Film 2mg BDF compared with Nicorette 2 mg (1mg/dose) Oral Spray.

Study on UK NRT Market Value

Nicoccino: Made to Pharmaceutical Standards*** Made to Pharmaceutical standards in a US FDA approved facility.
Produced with Pharmacopeia graded substances.

Clinical trials:
BK/PE Clinical Trial carried out by St Gorans Department of Medicine, Stockholm.

Key Study objectives:
Evaluate if Nicotine BDF (Nicoccino) achieved a comparable pharmacokinetic profile compared to Nicorette Oral Spray.
Compare overall subjective satisfaction between Nicoccino & Nicorette.
Evaluate the subjective urges to smoke following treatment with Nicoccino and Nicorette.
Evaluate the safety and tolerability of Nicotine BDF when administered as a single dose

About Nicoccino Holding AB

Nicoccino produces and markets an innovative and patented, tobacco-free nicotine consumer product. The product has the same name as the company - Nicoccino™– and is manufactured through partners.

Nicoccino™ is currently sold in the UK, Germany, Czech Republic and through our online platform ( Nicoccino`s head quarter is located in Täby outside of Stockholm with a sales office in London. The company's shares have been listed on Nasdaq Stockholm First North since June 2014 and can be found under the abbreviation NICO.

Remium Nordic AB is Nicoccino Holding's Certified Adviser.

Nicoccino Press Contacts:

Natalie Sutton/Vicky Major
Proud PR Tel: 01276 679570 / 07768 026197

This press release was distributed by ResponseSource Press Release Wire on behalf of Proud PR in the following categories: Medical & Pharmaceutical, Retail & Fashion, for more information visit